Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1998 Jan;227(1):70–79. doi: 10.1097/00000658-199801000-00011

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

J R Madariaga 1, S Iwatsuki 1, S Todo 1, R G Lee 1, W Irish 1, T E Starzl 1
PMCID: PMC1191175  PMID: 9445113

Abstract

OBJECTIVE: To analyze a single center's 14-year experience with 62 consecutive patients with hilar (HCCA) and peripheral (PCCA) cholangiocarcinomas. SUMMARY BACKGROUND DATA: Long-term survival after surgical treatment of HCCA and PCCA has been poor. METHODS: From March 1981 until December 1994, 62 consecutive patients with HCCA (n = 28) and PCCA (n = 34) underwent surgical treatment. The operations were individualized and included local excision of the tumor and suprapancreatic bile duct, lymph node dissection, vascular reconstruction, and subtotal hepatectomy. Clinical and pathologic risk factors were examined for prognostic influence. RESULTS: Patients were followed for a median of 25 months (12-102 months). Postoperative morbidity and mortality (at 30 days) were 32% and 14%, respectively, for HCCA and 24% and 6% for PCCA. The survival rates for HCCA and PCCA were 79% (+/-8%) and 67% (+/-8%) at 1 year; 39% (+/-10%) and 40% (+/-9%) at 3 years; and 8% (+/-7%) and 35% (+/-10%) at 5 years, respectively. The median survival was 24 (+/-4) months for HCCA and 19 (+/-8) months for PCCA. The disease-free survival rates for HCCA and PCCA were 85% (+/-10%) and 77% (+/-9%) at 1 year; 18% (+/-11%) and 41% (+/-12%) at 3 years; and 18% (+/-11%) and 41% (+/-12%) at 5 years, respectively. Nearly 80% of these patients had TNM stage IV tumors. With HCCA, no risk factors were associated with patient survival. For PCCA, multiple tumors (relative risk [RR] = 3.5; 95% confidence interval [CI] = 1.2-10.5) and incomplete resection (RR = 8.3; 95% CI = 2.3-29.6) were independently associated with a worse prognosis. For HCCA, there was a trend for lower disease-free survival in females (p = 0.056; log rank test). For PCCA, tumor size >5 cm was the only factor associated with disease recurrence (p = 0.024; log rank test). CONCLUSIONS: Even though rare, 5-year survival by resection can be achieved in both HCCA and PCCA, but new adjuvant treatments are clearly needed.

Full text

PDF
70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALTEMEIER W. A., GALL E. A., ZINNINGER M. M., HOXWORTH P. I. Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg. 1957 Sep;75(3):450–461. doi: 10.1001/archsurg.1957.01280150140015. [DOI] [PubMed] [Google Scholar]
  2. Bengmark S., Ekberg H., Evander A., Klofver-Stahl B., Tranberg K. G. Major liver resection for hilar cholangiocarcinoma. Ann Surg. 1988 Feb;207(2):120–125. doi: 10.1097/00000658-198802000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bismuth H., Corlette M. B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975 Feb;140(2):170–178. [PubMed] [Google Scholar]
  4. Bismuth H., Nakache R., Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992 Jan;215(1):31–38. doi: 10.1097/00000658-199201000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blumgart L. H., Hadjis N. S., Benjamin I. S., Beazley R. Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet. 1984 Jan 14;1(8368):66–70. doi: 10.1016/s0140-6736(84)90002-3. [DOI] [PubMed] [Google Scholar]
  6. Boerma E. J. Research into the results of resection of hilar bile duct cancer. Surgery. 1990 Sep;108(3):572–580. [PubMed] [Google Scholar]
  7. Chen M. F., Jan Y. Y., Wang C. S., Jeng L. B., Hwang T. L. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer. 1989 Dec 1;64(11):2226–2232. doi: 10.1002/1097-0142(19891201)64:11<2226::aid-cncr2820641107>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  8. Choi B. I., Park J. H., Kim Y. I., Yu E. S., Kim S. H., Kim W. H., Kim C. Y., Han M. C. Peripheral cholangiocarcinoma and clonorchiasis: CT findings. Radiology. 1988 Oct;169(1):149–153. doi: 10.1148/radiology.169.1.2843940. [DOI] [PubMed] [Google Scholar]
  9. EDMONDSON H. A., STEINER P. E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954 May;7(3):462–503. doi: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  10. Evander A., Fredlund P., Hoevels J., Ihse I., Bengmark S. Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts. Ann Surg. 1980 Jan;191(1):23–29. doi: 10.1097/00000658-198001000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. González González D., Gerard J. P., Maners A. W., De la Lande-Guyaux B., Van Dijk-Milatz A., Meerwaldt J. H., Bosset J. F., Van Dijk J. D. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis. 1990 May;10(2):131–141. doi: 10.1055/s-2008-1040466. [DOI] [PubMed] [Google Scholar]
  12. Hadjis N. S., Blenkharn J. I., Alexander N., Benjamin I. S., Blumgart L. H. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery. 1990 Jun;107(6):597–604. [PubMed] [Google Scholar]
  13. KLATSKIN G. ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med. 1965 Feb;38:241–256. doi: 10.1016/0002-9343(65)90178-6. [DOI] [PubMed] [Google Scholar]
  14. Kurashina M., Kozuka S., Nakasima N., Hirabayasi N., Ito M. Relationship of intrahepatic bile duct hyperplasia to cholangiocellular carcinoma. Cancer. 1988 Jun 15;61(12):2469–2474. doi: 10.1002/1097-0142(19880615)61:12<2469::aid-cncr2820611214>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  15. Lygidakis N. J., Brummelkamp W. H., Lubbers M. E., Huibregtse K., Tijtgat G. N., Schenk K. E., van Gulik T. M. A new surgical approach for the management of carcinoma of the junction of the main hepatic ducts. Surg Annu. 1986;18:297–310. [PubMed] [Google Scholar]
  16. Lygidakis N. J., Van der Heyde M. N., Verbeek P. C., Van Leeuwen D. J. Technical considerations for the management of primary cholangiocarcinoma of the porta hepatis. Semin Liver Dis. 1990 May;10(2):126–130. doi: 10.1055/s-2008-1040465. [DOI] [PubMed] [Google Scholar]
  17. Lygidakis N. J., van der Heyde M. N., Houthoff H. J. Surgical approaches to the management of primary biliary cholangiocarcinoma of the porta hepatis: the decision-making dilemma. Hepatogastroenterology. 1988 Dec;35(6):261–267. [PubMed] [Google Scholar]
  18. Lygidakis N. J., van der Heyde M. N., van Dongen R. J., Kromhout J. G., Tytgat G. N., Huibregtse K. Surgical approaches for unresectable primary carcinoma of the hepatic hilus. Surg Gynecol Obstet. 1988 Feb;166(2):107–114. [PubMed] [Google Scholar]
  19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  20. Nakajima T., Kondo Y., Miyazaki M., Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol. 1988 Oct;19(10):1228–1234. doi: 10.1016/s0046-8177(88)80156-4. [DOI] [PubMed] [Google Scholar]
  21. Nimura Y., Hayakawa N., Kamiya J., Kondo S., Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990 Jul-Aug;14(4):535–544. doi: 10.1007/BF01658686. [DOI] [PubMed] [Google Scholar]
  22. Okuda K., Kubo Y., Okazaki N., Arishima T., Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer. 1977 Jan;39(1):232–246. doi: 10.1002/1097-0142(197701)39:1<232::aid-cncr2820390137>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  23. Qualman S. J., Haupt H. M., Bauer T. W., Taxy J. B. Adenocarcinoma of the hepatic duct junction. A reappraisal of the histologic criteria of malignancy. Cancer. 1984 Apr 1;53(7):1545–1551. doi: 10.1002/1097-0142(19840401)53:7<1545::aid-cncr2820530721>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  24. Rossi R. L., Heiss F. W., Beckmann C. F., Braasch J. W. Management of cancer of the bile duct. Surg Clin North Am. 1985 Feb;65(1):59–78. doi: 10.1016/s0039-6109(16)43533-4. [DOI] [PubMed] [Google Scholar]
  25. Sakaguchi S., Nakamura S. Surgery of the portal vein in resection of cancer of the hepatic hilus. Surgery. 1986 Mar;99(3):344–349. [PubMed] [Google Scholar]
  26. Schlinkert R. T., Nagorney D. M., Van Heerden J. A., Adson M. A. Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg. 1992;5(2):95–102. doi: 10.1155/1992/93976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stambuk E. C., Pitt H. A., Pais S. O., Mann L. L., Lois J. F., Gomes A. S. Percutaneous transhepatic drainage. Risks and benefits. Arch Surg. 1983 Dec;118(12):1388–1394. doi: 10.1001/archsurg.1983.01390120018006. [DOI] [PubMed] [Google Scholar]
  28. Starzl T. E., Bell R. H., Beart R. W., Putnam C. W. Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet. 1975 Sep;141(3):429–437. [PMC free article] [PubMed] [Google Scholar]
  29. Starzl T. E., Iwatsuki S., Shaw B. W., Jr, Waterman P. M., Van Thiel D., Diliz H. S., Dekker A., Bron K. M. Left hepatic trisegmentectomy. Surg Gynecol Obstet. 1982 Jul;155(1):21–27. [PMC free article] [PubMed] [Google Scholar]
  30. Starzl T. E., Koep L. J., Weil R., 3rd, Lilly J. R., Putnam C. W., Aldrete J. A. Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet. 1980 Feb;150(2):208–214. [PMC free article] [PubMed] [Google Scholar]
  31. Starzl T. E., Todo S., Tzakis A., Podesta L., Mieles L., Demetris A., Teperman L., Selby R., Stevenson W., Stieber A. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg. 1989 Sep;210(3):374–386. doi: 10.1097/00000658-198909000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Su C. H., Tsay S. H., Wu C. C., Shyr Y. M., King K. L., Lee C. H., Lui W. Y., Liu T. J., P'eng F. K. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996 Apr;223(4):384–394. doi: 10.1097/00000658-199604000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sugiura Y., Nakamura S., Iida S., Hosoda Y., Ikeuchi S., Mori S., Sugioka A., Tsuzuki T. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery. 1994 Apr;115(4):445–451. [PubMed] [Google Scholar]
  34. Suzuki M., Takahashi T., Ouchi K., Matsuno S. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer. 1989 Aug 1;64(3):658–666. doi: 10.1002/1097-0142(19890801)64:3<658::aid-cncr2820640316>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  35. Tompkins R. K., Thomas D., Wile A., Longmire W. P., Jr Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg. 1981 Oct;194(4):447–457. doi: 10.1097/00000658-198110000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vauthey J. N., Blumgart L. H. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis. 1994 May;14(2):109–114. doi: 10.1055/s-2007-1007302. [DOI] [PubMed] [Google Scholar]
  37. Weinbren K., Mutum S. S. Pathological aspects of cholangiocarcinoma. J Pathol. 1983 Feb;139(2):217–238. doi: 10.1002/path.1711390210. [DOI] [PubMed] [Google Scholar]
  38. White T. T. Skeletization resection and central hepatic resection in the treatment of bile duct cancer. World J Surg. 1988 Feb;12(1):48–51. doi: 10.1007/BF01658485. [DOI] [PubMed] [Google Scholar]
  39. Yamamoto J., Kosuge T., Takayama T., Shimada K., Makuuchi M., Yoshida J., Sakamoto M., Hirohashi S., Yamasaki S., Hasegawa H. Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery. 1992 Jun;111(6):617–622. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES